Skip to content
value.today

Solta Medical Inc.

Formerly Thermage, Inc.

Total raised
$17 M
1 round on record
Latest round
$17 M
Jan 2010
First round on record
Jan 2010
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Solta Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2013$26 MIssued in a merger or acquisition$10 to $50 million

Solta Medical Inc.: Private sale, Feb 2013

Investors in this round

173 investors had bought by the notice of Apr 9, 2013: 173 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Doug Heigel · Executive Officer
  • H. Daniel Ferrari · Executive Officer
  • Jeff Nardoci · Executive Officer
  • John Glenn · Executive Officer
  • Stephen Fanning · Executive Officer, Director
  • Cathy McCarthy · Director
  • David Holthe · Director
  • Edward Knowlton · Director
  • Eric Stang · Director
  • Harold Covert · Director
  • Linda Graebner · Director
  • Mark Sieczkarek · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Common Stock in connection with the acquisition of Sound Surgical Technologies LLC.”

Signed by John F. Glenn, Chief financial officer. Source: SEC Form D, newest notice filed Apr 9, 2013. Read the notice at the SEC.

equitySEC
Feb 2010$5 MIssued in a merger or acquisition$2 to $10 million

Solta Medical Inc.: Private sale, Feb 2010

Investors in this round

4 investors had bought by the notice of Mar 5, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $16 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Clint Carnell · Executive Officer
  • Doug Heigel · Executive Officer
  • H. Daniel Ferrari · Executive Officer
  • Jeff Nardoci · Executive Officer
  • John Glenn · Executive Officer
  • Len DeBenedictis · Executive Officer, Director
  • Stephen Fanning · Executive Officer, Director
  • William Brodie · Executive Officer
  • Cathy McCarthy · Director
  • Edward Knowlton · Director
  • Eric Stang · Director
  • Harold Covert · Director
  • Mark Sieczkarek · Director
  • Marti Morfitt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Common Stock in connection with the aquisition of Aesthera Corporation.”

Signed by John F. Glenn, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 5, 2010. Read the notice at the SEC.

equitySEC
Jan 2010$17 MNo. 1$10 to $50 million

Solta Medical Inc.: Raise no. 1, Jan 2010

Investors in this round

9 investors had bought by the notice of Jan 21, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$883,415
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Clint Carnell · Executive Officer
  • Doug Heigel · Executive Officer
  • H. Daniel Ferrari · Executive Officer
  • Jeff Nardoci · Executive Officer
  • John Glenn · Executive Officer
  • Len DeBenedictis · Executive Officer, Director
  • Stephen Fanning · Executive Officer, Director
  • William Brodie · Executive Officer
  • Cathy McCarthy · Director
  • Edward Knowlton · Director
  • Eric Stang · Director
  • Harold Covert · Director
  • Mark Sieczkarek · Director
  • Marti Morfitt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Morgan Keegan & Company, Inc. (CRD 4161) · Memphis, TnSold in no state named

Signed by John F. Glenn, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 21, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Solta Medical Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2013).

    SEC Form D · Apr 2013

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2013

That is all the official record says: Solta Medical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Solta Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Solta Medical Inc.
NameRoleNamed in
Doug HeigelExecutive officerApr 2013
H. Daniel FerrariExecutive officerApr 2013
Jeff NardociExecutive officerApr 2013
John GlennExecutive officerApr 2013
Stephen FanningExecutive officerApr 2013
Clint CarnellExecutive officerMar 2010
Len DeBenedictisExecutive officerMar 2010
William BrodieExecutive officerMar 2010
Cathy McCarthyDirectorApr 2013
David HoltheDirectorApr 2013
Edward KnowltonDirectorApr 2013
Eric StangDirectorApr 2013
Harold CovertDirectorApr 2013
Linda GraebnerDirectorApr 2013
Mark SieczkarekDirectorApr 2013
Stephen FanningDirectorApr 2013
Len DeBenedictisDirectorMar 2010
Marti MorfittDirectorMar 2010